Diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
It is very uncertain whether probiotics changes any diarrhoea compared with other active treatment (very low certainty).
1 finding from 1 review
Quality of life · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Grade ≥ 3 diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
Probiotics may leads to lower severity of diarrhoea: grade 3 or higher compared with other active treatment (low certainty).
1 finding from 1 review
Time to rescue medication ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Requiring rescue medication for diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
It is very uncertain whether probiotics changes requiring rescue medication for diarrhoea compared with other active treatment (very low certainty).
1 finding from 1 review
Adverse events · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
All‐cause mortality · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Reduction in severity of diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Median (mean) time to use of rescue medication · participants with cancer treated with radiotherapy (with or without chemotherapy)
2 findings from 1 review
Requiring rescue medication for diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
Probiotics showed no clear difference in requiring rescue medication for diarrhoea compared with placebo (moderate certainty).
2 findings from 1 review
Diarrhoea (grade 2+) · participants with cancer treated with radiotherapy (with or without chemotherapy)
Probiotics showed no clear difference in diarrhoea grade 2 or higher compared with placebo (low certainty).
1 finding from 1 review
Adverse events · participants with cancer treated with radiotherapy (with or without chemotherapy)
2 findings from 1 review
All‐cause mortality · participants with cancer treated with radiotherapy (with or without chemotherapy)
2 findings from 1 review
Grade 3 to 4 diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Diarrhoea grade 4 · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Mortality before hospital discharge · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes mortality before hospital discharge compared with invasive respiratory therapy (very low certainty).
1 finding from 1 review
Endotracheal intubation or reintubation To discharge · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes chronic lung disease compared with invasive respiratory therapy (very low certainty).
1 finding from 1 review